Genprex Inc (GNPX)
2.35
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
2.35
0.00 (0.00%)
After-Hours: 20:00
Genprex Net Income (TTM): -27.63M for March 31, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -27.63M |
December 31, 2023 | -30.86M |
September 30, 2023 | -31.45M |
June 30, 2023 | -29.85M |
March 31, 2023 | -27.63M |
December 31, 2022 | -23.74M |
September 30, 2022 | -23.97M |
June 30, 2022 | -21.26M |
March 31, 2022 | -19.49M |
December 31, 2021 | -20.66M |
September 30, 2021 | -19.14M |
June 30, 2021 | -18.48M |
March 31, 2021 | -18.87M |
December 31, 2020 | -17.94M |
September 30, 2020 | -15.14M |
Date | Value |
---|---|
June 30, 2020 | -14.74M |
March 31, 2020 | -14.06M |
December 31, 2019 | -10.65M |
September 30, 2019 | -11.66M |
June 30, 2019 | -11.47M |
March 31, 2019 | -13.84M |
December 31, 2018 | -12.37M |
September 30, 2018 | -9.608M |
June 30, 2018 | -8.137M |
March 31, 2018 | -3.257M |
December 31, 2017 | -3.314M |
September 30, 2017 | -3.647M |
June 30, 2017 | -3.651M |
March 31, 2017 | -4.56M |
December 31, 2016 | -4.132M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-31.45M
Minimum
Sep 2023
-10.65M
Maximum
Dec 2019
-20.44M
Average
-19.31M
Median
Net Income (TTM) Benchmarks
Lifecore Biomedical Inc | -100.12M |
Jaguar Health Inc | -38.32M |
Aquestive Therapeutics Inc | -28.77M |
TFF Pharmaceuticals Inc | -19.93M |
Calidi Biotherapeutics Inc | -23.94M |